M1X Global's Mark Lurie and Jordan Goldman on USDM1, the Marshall Islands bondissued natively on chain, and what ...

Kunal Bhatia, CEO and co-founder, & Vignesh Baskaran, CTO and cofounder have both spent more than a decade building AI ...

The future of East Asia destination marketing lies in something far more tangible yet notoriously underutilised: intellectual ...

One vision can be described as pragmatic and institutionally conservative, suggesting that payments should be made more ...

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing ...

A startup accelerator that provides stage-by-stage growth support — from seed investment through the Ministry of SMEs and Startups' TIPS program to follow ...

This article is authored by Trisha Varma, director, Global Knowledge Hub, ISDM and Amita Chauhan, board member, SVP India.

NeuroSense has already received FDA clearance to initiate its pivotal Phase 3 PARAGON trial. Together, these clinical, biomarker and regulatory advances provide the foundation for a more focused and ...

Market Intelligence analyst Jeff Lipton argues data center expansion will likely create a reallocation of risk and the market ...

Telviva launches intelligent digital agent Viva to fast-track enterprise AI adoption for SA businessesViva marks a paradigm shift from rigid, menu-driven assistants to an integrated digital agent ...

Historical events hold lessons about collaboration and competition in space that could inform how experts plan for the ...